Drugs / Omega-3 fatty acid ethylester90
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00549692 | Nov 2007 → Aug 2012 | IgA glomerulonephritis | Kuhnil Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01596842 Comparator | May → Dec 2012 | vitamin D deficiency | Dong-A University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3 fatty acid ethylester 90 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01596842 ↗ |